180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters
March 25, 2021 08:30 ET
|
180 Life Sciences Corp.
NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — 180 Life Sciences Corp. (NASDAQ: ATNF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
March 24, 2021 08:30 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3 clinical...
180 Life Sciences Corp. to Present at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC
March 08, 2021 13:30 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement
February 24, 2021 16:00 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. Announces $11.7 Million Private Placement
February 19, 2021 09:00 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference
January 05, 2021 14:50 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. to Present at the 13th Annual LD Micro Main Event Conference on Tuesday, December 15th at 1:40 PM EST
December 03, 2020 11:08 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) ("180 Life Sciences" or "the Company"), a clinical-stage biotechnology company with its lead indication...
180 Life Sciences Corp. to Ring Nasdaq Opening Bell on November 27, 2020
November 24, 2020 10:00 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants
November 23, 2020 08:30 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
November 17, 2020 08:00 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...